Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB998

Introduced
3/12/25  

Caption

Medical Supply Chain Resiliency Act

Impact

The implications of SB998 on state laws center on its potential to centralize regulatory authority and harmonize standards concerning medical goods. By allowing the President to remove trade barriers with trusted partners, the bill is expected to improve access to essential medical supplies, thereby supporting both national security and public health objectives. In practice, this could streamline the importation of critical medical goods while fostering better compliance with regulatory standards among trading nations. The bill also involves provisions for consulting Congress and ensuring oversight during negotiations, thereby maintaining a balance between executive authority and legislative oversight.

Summary

SB998, formally titled the Medical Supply Chain Resiliency Act, seeks to enhance the resilience of the United States' medical supply chain by enabling the President to negotiate trade agreements for the reciprocal elimination of duties and other restrictions related to medical goods. This proposal comes in the wake of the COVID-19 pandemic, which exposed significant vulnerabilities in the nation's medical supply chains and raised concerns about dependence on foreign suppliers, particularly those in politically unstable or unreliable countries. Through these agreements, the bill aims to ensure that the U.S. can meet its public health needs in times of emergency.

Contention

While the bill has gained support for addressing urgent needs in the medical supply chain, it has also faced scrutiny. Critics may argue that such agreements could undermine local manufacturers by prioritizing imports over domestically produced goods. Moreover, there is ongoing concern regarding the adequacy of protections for intellectual property and the risks associated with reliance on foreign medical supplies. Achieving a consensus on how to balance these concerns with the urgent need for availability and accessibility of medical goods is likely to be a point of contention as the bill is discussed in legislative sessions.

Companion Bills

US HB2213

Same As Medical Supply Chain Resiliency Act

Previously Filed As

US SB2115

Medical Supply Chain Resiliency Act

US HB4307

Medical Supply Chain Resiliency Act

US HB6571

Promoting Resilient Supply Chains Act of 2023

US SB4375

Promoting Resilient Supply Chains Act of 2024

US HR1082

Calling upon the International Seabed Authority to adopt regulations allowing the collection of critical minerals from the international seabed area, which will enable America to regain reliable and responsible supply chains, provide high-wage jobs for United States citizens, secure supply chains away from the People's Republic of China's dominance of the critical mineral supply chain, and for other purposes.

US HB826

Supply Chain Security and Resilience Act

US SB4702

Critical Mineral Supply Chain Realignment Act of 2024

US SB2454

Pharmaceutical Supply Chain Security Act

US HB6909

COBALT Supply Chain Act China’s Odious and Brutally Atrocious Labor Trafficking Supply Chain Act

US SB3866

Declaring Our Energy Independence from China Act of 2024

Similar Bills

US HB2213

Medical Supply Chain Resiliency Act

US HB1743

UNITED Act Undertaking Negotiations on Investment and Trade for Economic Dynamism Act

US HB8958

NASA Reauthorization Act of 2024

US HB7440

Financial Services Innovation Act of 2024

US SB5451

A bill to enhance the economic and national security of the United States by securing a reliable supply of critical minerals and rare earth elements through trade agreements and strategic partnerships.

US SB429

STRATEGIC Minerals Act Securing Trade and Resources for Advanced Technology, Economic Growth, and International Commerce in Minerals Act

US HB33

United States-Taiwan Tax Agreement Authorization Act United States-Taiwan Expedited Double-Tax Relief Act

US HB9501

Stand with Ukraine Act of 2024